Showing results (1-10 of 488) with videos related to
Sort By:
Pageof 49
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 3, 2010
The McDonald Criteria for Multiple Sclerosis: time for clarificationChristopher H Hawkes, Gavin GiovannoniMultiple Sclerosis and Related Disorders|April 17, 2015
The diagnostic criteria for multiple sclerosis: From Charcot to McDonaldArie Gafson, Gavin Giovannoni, Christopher H HawkesMultiple Sclerosis and Related Disorders|August 15, 2023
Is it ethical to use teriflunomide as an active comparator in phase 3 trials?Gavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.Multiple Sclerosis and Related Disorders|August 27, 2023
CNS resilience in the progression of MSGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.Multiple Sclerosis and Related Disorders|February 22, 2025
Infectious mononucleosis is a more realistic target for preventing multiple sclerosisGavin Giovannoni, Christopher H Hawkes, Jeannette Lechner-Scott, et al.European Neurology|November 27, 2009
Multiple sclerosis, lymphoma and nasopharyngeal carcinoma: the central role of Epstein-Barr virus?Alexander E S Rolls, Gavin Giovannoni, Cris S Constantinescu, et al.Multiple Sclerosis and Related Disorders|March 2, 2023
Myopia in late adolescence and subsequent multiple sclerosis among menAyako Hiyoshi, Christopher H Hawkes, James E Neffendorf, et al.Multiple Sclerosis and Related Disorders|August 13, 2018
Epstein Barr virus shedding in multiple sclerosis: Similar frequencies of EBV in saliva across separate patient cohortsDavid W Holden, Julian Gold, Christopher H Hawkes, et al.Annals of Neurology|October 17, 2012
Meta-analysis of early nonmotor features and risk factors for Parkinson diseaseAlastair J Noyce, Jonathan P Bestwick, Laura Silveira-Moriyama, et al.Current Opinion in Neurology|April 11, 2018
Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment paradigmGavin GiovannoniPageof 49